InvestSMART

Company announcements

leave blank for all companies
leave blank for all announcements
announcements

~ We have limited the announcement data displayed on our website to the past 12 months to ensure its accuracy and usefulness.
Search Results
Company Sector Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $2,071 DAYBU recommended for approval in the European Union 29 Jun 2026 7:43AM $12.200 $16.340 risen by 33.93%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $2,071 Application for quotation of securities - NEU 18 Jun 2026 4:49PM $13.250 $16.340 risen by 23.32%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $2,071 Notification of cessation of securities - NEU 1 Jun 2026 5:47PM $14.210 $16.340 risen by 14.99%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $2,071 Notification regarding unquoted securities - NEU 1 Jun 2026 5:40PM $14.210 $16.340 risen by 14.99%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $2,071 Results of Meeting 27 May 2026 4:00PM $13.810 $16.340 risen by 18.32%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $2,071 AGM Chair Address & CEO Presentation 27 May 2026 1:22PM $14.410 $16.340 risen by 13.39%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $2,071 Update - Notification of buy-back - NEU 14 May 2026 7:30AM $12.710 $16.340 risen by 28.56%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $2,071 Launch of Investor Hub to enhance shareholder engagement 12 May 2026 3:56PM $12.870 $16.340 risen by 26.96%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $2,071 Notification of cessation of securities - NEU 12 May 2026 8:34AM $13.390 $16.340 risen by 22.03%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $2,071 Update - Notification of buy-back - NEU 12 May 2026 8:32AM $13.390 $16.340 risen by 22.03%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $2,071 Update - Notification of buy-back - NEU 11 May 2026 8:45AM $12.800 $16.340 risen by 27.66%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $2,071 Q1 2026 DAYBUE net sales US$101m, up 20% from Q1 2025 7 May 2026 9:53AM $12.320 $16.340 risen by 32.63%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $2,071 Update - Notification of buy-back - NEU 6 May 2026 10:31AM $12.510 $16.340 risen by 30.62%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $2,071 Update - Notification of buy-back - NEU 29 Apr 2026 8:45AM $11.930 $16.340 risen by 36.97%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $2,071 Virtual AGM online guide 24 Apr 2026 1:27PM $12.225 $16.340 risen by 33.66%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $2,071 Notice of Annual General Meeting/Proxy Form 24 Apr 2026 1:22PM $12.225 $16.340 risen by 33.66%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $2,071 Appendix 4G 24 Apr 2026 1:05PM $12.260 $16.340 risen by 33.28%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $2,071 2025 Annual Report to shareholders 24 Apr 2026 12:58PM $12.140 $16.340 risen by 34.60%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $2,071 Update - Notification of buy-back - NEU 21 Apr 2026 8:56AM $12.480 $16.340 risen by 30.93%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $2,071 Update - Notification of buy-back - NEU 20 Apr 2026 8:32AM $12.490 $16.340 risen by 30.82%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $2,071 Update - Notification of buy-back - NEU 17 Apr 2026 8:48AM $12.480 $16.340 risen by 30.93%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $2,071 Notification of cessation of securities - NEU 10 Apr 2026 4:55PM $12.520 $16.340 risen by 30.51%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $2,071 DAYBUE STIX now broadly available in US for Rett syndrome 8 Apr 2026 9:47AM $12.300 $16.340 risen by 32.85%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $2,071 Notification of cessation of securities - NEU 26 Mar 2026 5:49PM $11.850 $16.340 risen by 37.89%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $2,071 Update - Notification of buy-back - NEU 24 Mar 2026 8:40AM $11.490 $16.340 risen by 42.21%

1 - 25 of 821 results

Page 1 of 33

  • + Company announcements and prices are delayed by at least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.